AKT1 and neoplasm: Taking EGFR, PI3K, AKT, and NFκB together, Our finding was in accordance with the report that EGFR activation could further trigger the PI3K-AKT-NFκB signaling axis and eventually cause tumor cells proliferation (Engelman et al., 2006; Zhang et al., 2014).